Evaluation of the Transplant Recipient
By:
Puneet Sood Department of Medicine, University of California San Francisco, San Francisco, California

Search for other papers by Puneet Sood in
Current site
Google Scholar
PubMed Close
,
Pascale Khairallah Department of Medicine, University of California San Francisco, San Francisco, California

Search for other papers by Pascale Khairallah in
Current site
Google Scholar
PubMed Close
, and
Chethan Puttarajappa Department of Medicine and Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Search for other papers by Chethan Puttarajappa in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 23: Issue 5
Published Online:
Dec 2024
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand
Cover Nephrology Self-Assessment Program
Copyright:
Copyright © 2024 by the American Society of Nephrology 2024
Page Count:
0
Article Category:
Research Article
Print Publication Date:
01 Dec 2024
Published Online:
Dec 2024
  • 1.

    Harding JL, Dixon MA, Di M, Hogan J, Pastan SO, Patzer RE: Setting reasonable goals for kidney transplant referral among dialysis facilities. BMC Nephrol 25: 235, 2024 10.1186/s12882-024-03671-2 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Reese PP, Shults J, Bloom RD, Mussell A, Harhay MN, Abt P, et al.: Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates. Am J Kidney Dis 66: 837–845, 2015 10.1053/j.ajkd.2015.05.015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Haller MC, Kammer M, Oberbauer R: Dialysis vintage and outcomes in renal transplantation. Nephrol Dial Transplant 34: 555–560, 2019 10.1093/ndt/gfy099 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Haller MC, Kainz A, Baer H, Oberbauer R: Dialysis vintage and outcomes after kidney transplantation: A retrospective cohort study. Clin J Am Soc Nephrol 12: 122–130, 2017 10.2215/cjn.04120416 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, et al.: KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation 104: S11–S103, 2020 10.1097/TP.0000000000003136 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    United States Renal Data System: 2019 USRDS annual data report: Epidemiology of kidney disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2019

    • PubMed
    • Export Citation
  • 7.

    Harding JL, Gompers A, Di M, Drewery K, Pastan S, Rossi A, et al.: Sex/gender disparities in preemptive referrals for kidney transplantation. Kidney Int Rep 9: 2134–2145, 2024 10.1016/j.ekir.2024.04.025 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Hödlmoser S, Gehrig T, Antlanger M, Kurnikowski A, Lewandowski M, Krenn S, et al.: Sex differences in kidney transplantation: Austria and the United States, 1978–2018. Front Med (Lausanne) 8: 800933, 2021 10.3389/fmed.2021.800933 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Husain SA, Yu ME, King KL, Adler JT, Schold JD, Mohan S: Disparities in kidney transplant waitlisting among young patients without medical comorbidities. JAMA Intern Med 183: 1238–1246, 2023 10.1001/jamainternmed.2023.5013 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Wang J, Cho KC, Tantisattamo E: Socioeconomic disparities in kidney transplant access for patients with end-stage kidney disease within the All of Us Research Program. J Am Med Inform Assoc, 2024 10.1093/jamia/ocae178 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Shelton BA, Becker DJ, MacLennan PA, Sen B, Budhwani H, Locke JE: Racial disparities in access to the kidney transplant waitlist among people with human immunodeficiency virus. AIDS Patient Care STDS 37: 394–402, 2023 10.1089/apc.2023.0037 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Cannon RM, Anderson DJ, MacLennan P, Orandi BJ, Sheikh S, Kumar V, et al.: Perpetuating disparity: Failure of the kidney transplant system to provide the most kidney transplants to communities with the greatest need. Ann Surg 276: 597–604, 2022 10.1097/sla.0000000000005585 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Chen Y, Churilla B, Ahn JB, Quint EE, Sandal S, Musunuru A, et al.: Age disparities in access to first and repeat kidney transplantation. Transplantation 108: 845–853, 2024 10.1097/tp.0000000000004747 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Sandal S, Ahn J, Chen Y, Thompson V, Purnell TS, Cantarovich M, et al.: Differences in racial and ethnic disparities between first and repeat kidney transplantation. Transplantation 108: 2144–2152, 2024 10.1097/tp.0000000000005051 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Vinson AJ, Kiberd BA, West K, Mannon RB, Foster BJ, Tennankore KK: Disparities in access to preemptive repeat kidney transplant: Still missing the mark? Kidney360 3: 144–152, 2022 10.34067/kid.0003162021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Centers for Medicare & Medicaid Service: Increasing Organ Transplant Access (IOTA) Model. Available at: https://www.cms.gov/priorities/innovation/innovation-models/iota. Accessed October 17, 2024

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Daw J, Roberts M, Gillespie A, Verdery AM, Purnell TS: Testing the differential access hypothesis that Black kidney transplant candidates perceive social network access to fewer potential living donors than White candidates. Prog Transplant 33: 130–140, 2023 10.1177/15269248231164174 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Mathur AK, Goodrich N, Hong B, Smith AR, Mandell RJ, Warren PH, et al.: Use of federal reimbursement for living donor costs by racial and ethnic minorities: Implications for disparities in access to living donor transplantation [published online ahead of print May 21, 2024]. Transplantation doi:10.1097/TP.0000000000005013 2024 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Eneanya ND, Yang W, Reese PP: Reconsidering the consequences of using race to estimate kidney function. Jama 322: 113–114, 2019 10.1001/jama.2019.5774 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Diao JA, Wu GJ, Taylor HA, Tucker JK, Powe NR, Kohane IS, et al.: Clinical implications of removing race From estimates of kidney function. Jama 325: 184–186, 2021 10.1001/jama.2020.22124 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Zelnick LR, Leca N, Young B, Bansal N: Association of the estimated glomerular filtration rate with vs without a coefficient for race with time to eligibility for kidney transplant. JAMA Netw Open 4: e2034004, 2021 10.1001/jamanetworkopen.2020.34004 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Levey AS, Tighiouart H, Titan SM, Inker LA: Estimation of glomerular filtration rate with vs without including patient race. JAMA Intern Med 180: 793–795, 2020 10.1001/jamainternmed.2020.0045 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Levey AS, Titan SM, Powe NR, Coresh J, Inker LA: Kidney disease, race, and GFR estimation. Clin J Am Soc Nephrol 15: 1203–1212, 2020 10.2215/CJN.12791019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Delgado C, Baweja M, Burrows NR, Crews DC, Eneanya ND, Gadegbeku CA, et al.: Reassessing the inclusion of race in diagnosing kidney diseases: An interim report from the NKF-ASN Task Force. Am J Kidney Dis 78: 103–115, 2021 10.1053/j.ajkd.2021.03.008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    King KL, Yu M, Husain SA, Patzer RE, Sandra V, Reese PP, et al.: Contribution of estimates of glomerular filtration to the extensive disparities in preemptive listing for kidney transplant. Kidney Int Rep 8: 442–454, 2023 10.1016/j.ekir.2022.12.021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Chu CD, Powe NR, Crews DC, Tuot DS: CKD progression from the time of estimated GFR-based waitlist eligibility and racial disparities in transplant access. Am J Kidney Dis 79: 841–848.e1, 2022 10.1053/j.ajkd.2021.08.010 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Diao JA, Wu GJ, Wang JK, Kohane IS, Taylor HA, Tighiouart H, et al.: National projections for clinical implications of race-free creatinine-based GFR estimating equations. J Am Soc Nephrol 34: 309–321, 2023 10.1681/ASN.2022070818 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Cheng XS, Liu S, Han J, Stedman MR, Baiocchi M, Tan JC, et al.: Association of pretransplant coronary heart disease testing with early kidney transplant outcomes. JAMA Intern Med 183: 134–141, 2023 10.1001/jamainternmed.2022.6069 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Lee M-S, Batiste C, Onwuzurike J, Elkoustaf R, Wu Y-L, Chen W, et al.: Pretransplant cardiac stress testing and transplant wait time in kidney transplantation candidates. Open Heart 11: e002738, 2024 10.1136/openhrt-2024-002738 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Cheng XS, VanWagner LB, Costa SP, Axelrod DA, Bangalore S, Norman SP, American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Cardiovascular Radiology and Intervention, et al.: Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: A scientific statement from the American Heart Association: Endorsed by the American Society of Transplantation. Circulation 146: e299–e324, 2022 10.1161/cir.0000000000001104 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Nielsen MB, Dahl JN, Jespersen B, Ivarsen P, Birn H, Winther S: External validation of proposed American Heart Association algorithm for cardiovascular screening before kidney transplantation. J Am Heart Assoc 12: e031150, 2023 10.1161/jaha.123.031150 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, ISCHEMIA-CKD Research Group, et al.: Management of coronary disease in patients with advanced kidney disease. N Engl J Med 382: 1608–1618, 2020 10.1056/NEJMoa1915925 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Spertus JA, Jones PG, Maron DJ, Mark DB, O’Brien SM, Fleg JL, ISCHEMIA-CKD Research Group, et al.: Health status after invasive or conservative care in coronary and advanced kidney disease. N Engl J Med 382: 1619–1628, 2020 10.1056/NEJMoa1916374 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Edmonston DL, Parikh KS, Rajagopal S, Shaw LK, Abraham D, Grabner A, et al.: Pulmonary hypertension subtypes and mortality in CKD. Am J Kidney Dis 75: 713–724, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S: Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: A systematic review and meta-analysis. Am J Kidney Dis 72: 75–83, 2018 10.1053/j.ajkd.2017.11.018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG: Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 86: 1384–1388, 2008 10.1097/TP.0b013e318188d640 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37.

    Mehra S, Efird J, Christiano C, Sharma S: Pulmonary hypertension in patients undergoing kidney transplant—A single center experience. Int J Cardiovasc Res 2: 6, 2013 10.4172/2324-8602.1000153

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Nguyen MC, Po-Yu Chiang T, Massie AB, Bae S, Motter JD, Brennan DC, et al.: Kidney transplantation confers survival benefit for candidates with pulmonary hypertension. Transplant Direct 7: e738, 2021 10.1097/txd.0000000000001191 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Lentine KL, Lam NN, Caliskan Y, Xiao H, Axelrod DA, Costa SP, et al.: Incidence, clinical correlates, and outcomes of pulmonary hypertension after kidney transplantation: Analysis of linked US registry and Medicare billing claims. Transplantation 106: 666–675, 2022 10.1097/tp.0000000000003783 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Heybeli C, Bentall A, Wen J, Alexander MP, Buadi FK, Cosio FG, et al.: A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int 99: 707–715, 2021 10.1016/j.kint.2020.06.036 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41.

    Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, et al.: Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int 95: 405–411, 2019 10.1016/j.kint.2018.09.021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42.

    Law S, Cohen O, Lachmann HJ, Rezk T, Gilbertson JA, Rowczenio D, et al.: Renal transplant outcomes in amyloidosis. Nephrol Dial Transplant 36: 355–365, 2021 10.1093/ndt/gfaa293 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43.

    Leeaphorn N, Thongprayoon C, Chewcharat A, Hansrivijit P, Jadlowiec CC, Cummings LS, et al.: Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: An analysis of the 2000-2019 UNOS/OPTN database. Am J Transplant 21: 846–853, 2021 10.1111/ajt.16385 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44.

    Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform, et al.: Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition Cancer Staging Manual. CA Cancer J Clin 67: 472–492, 2017 10.3322/caac.21409 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45.

    Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, et al.: Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement. Am J Transplant 21: 475–483, 2021 10.1111/ajt.16324 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46.

    Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, et al.: Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. Am J Transplant 21: 460–474, 2021 10.1111/ajt.16318 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Mayrdorfer M, Liefeldt L, Wu K, Rudolph B, Zhang Q, Friedersdorff F, et al.: Exploring the complexity of death-censored kidney allograft failure. J Am Soc Nephrol 32: 1513–1526, 2021 10.1681/asn.2020081215 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Knoers N, van Eerde AM: The role of genetic testing in adult CKD. J Am Soc Nephrol 35: 1107–1118, 2024 10.1681/asn.0000000000000401 PubMed

  • 49.

    Hengel FE, Dehde S, Lassé M, Zahner G, Seifert L, Schnarre A, International Society of Glomerular Disease, et al.: Autoantibodies targeting nephrin in podocytopathies. N Engl J Med 391: 422–433, 2024 10.1056/NEJMoa2314471 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    Sethi S, Fervenza FC: Membranous nephropathy—Diagnosis and identification of target antigens. Nephrol Dial Transplant 39: 600–606, 2024 10.1093/ndt/gfad227 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51.

    Kounoue N, Oguchi H, Hashiguchi A, Honda K, Kang D, Mikami T, et al.: Complement receptor 1 enhancement in recurrent membranous nephropathy following kidney transplantation: A case report. Kidney Med 6: 100876, 2024 10.1016/j.xkme.2024.100876 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52.

    Fila M, Debiec H, Perrochia H, Djouadi N, Verpont M-C, Buob D, et al.: Recurrence of anti-semaphorin 3B-mediated membranous nephropathy after kidney transplantation. J Am Soc Nephrol 33: 503–509, 2022 10.1681/asn.2021101323 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    Hullekes F, Uffing A, Verhoeff R, Seeger H, von Moos S, Mansur J, et al.: Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study. Am J Transplant 24: 1016–1026, 2024 10.1016/j.ajt.2024.01.036 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54.

    Lum EL, Zuckerman JE, Abdelnour L, Terenzini J, Singh G, Bunnapradist S: Pretransplant treatment to avoid recurrent membranous nephropathy in a kidney transplant recipient: A case report. Kidney Med 6: 100822, 2024 10.1016/j.xkme.2024.100822 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55.

    Jäger C, Stampf S, Molyneux K, Barratt J, Golshayan D, Hadaya K, et al.: Recurrence of IgA nephropathy after kidney transplantation: Experience from the Swiss transplant cohort study. BMC Nephrol 23: 178, 2022 10.1186/s12882-022-02802-x PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56.

    Nissaisorakarn P, Fadakar PK, Safa K, Lundquist AL, Riella CV, Riella LV: A pragmatic approach to selective genetic testing in kidney transplant candidates. Front Transplant 2: 1342471, 2023 10.3389/frtra.2023.1342471 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57.

    Ma BM, Elefant N, Tedesco M, Bogyo K, Vena N, Murthy SK, et al.: Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients. Kidney Int 106: 115–125, 2024 10.1016/j.kint.2024.02.021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58.

    Ladin K, Daniels A, Osani M, Bannuru RR: Is social support associated with post-transplant medication adherence and outcomes? A systematic review and meta-analysis. Transplant Rev (Orlando) 32: 16–28, 2018 10.1016/j.trre.2017.04.001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59.

    Manay P, Ten Eyck P, Siniff E, Binns G, Sanders ML, Swee M, et al.: Psychosocial characteristics of patients evaluated for kidney transplant and associations with functional and frailty metrics at a veterans affairs hospital. Clin Transplant 36: e14530, 2022 10.1111/ctr.14530 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 60.

    Ladin K, Emerson J, Berry K, Butt Z, Gordon EJ, Daniels N, et al.: Excluding patients from transplant due to social support: Results from a national survey of transplant providers. Am J Transplant 19: 193–203, 2019 10.1111/ajt.14962 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61.

    Nghiem DM, Gomez J, Gloston GF, Torres DS, Marek RJ: Psychological assessment instruments for use in liver and kidney transplant evaluations: Scarcity of evidence and recommendations. J Pers Assess 102: 183–195, 2020 10.1080/00223891.2019.1694527 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 62.

    Schoot TS, Perry M, Hilbrands LB, van Marum RJ, Kerckhoffs APM: Kidney transplantation or dialysis in older adults-an interview study on the decision-making process. Age Ageing 51, 2022 10.1093/ageing/afac111 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 63.

    Vankova H, Schmalz M, Andel R, Rajnochova Bloudickova S: Frailty and depressive symptoms in older kidney transplant recipients: Opportunities for collaboration between transplant nephrologists and geriatricians. BMC Geriatr 24: 423, 2024 10.1186/s12877-024-04972-9 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 64.

    Bakthavatsalam A, Sibulesky L, Leca N, Rayhill SC, Bakthavatsalam R, Perkins JD: Impact of obesity on kidney transplant outcomes in older adults. Transplant Proc 56: 58–67, 2024 10.1016/j.transproceed.2023.11.017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65.

    Lopez-Soler RI, Joyce C, Cotiguala L, Aguirre O, Samra M, Trotter C, et al.: Utilization of hepatitis B viremic donors (NAT+) leads to improved kidney transplant access for older adult recipients with little to no wait time. Transpl Infect Dis 26: e14295, 2024 10.1111/tid.14295 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66.

    Bamforth RJ, Trachtenberg A, Ho J, Wiebe C, Ferguson TW, Rigatto C, et al.: Expanding access to high KDPI kidney transplant for recipients aged 60 y and older: Cost utility and survival. Transplant Direct 10: e1629, 2024 10.1097/txd.0000000000001629 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    Lynch RJ, Patzer RE, Pastan SO, Bowling CB, Plantinga LC: Recent history of serious fall injuries and posttransplant outcomes among US kidney transplant recipients. Transplantation 103: 1043–1050, 2019 10.1097/TP.0000000000002463 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 68.

    Chu NM, Gross AL, Shaffer AA, Haugen CE, Norman SP, Xue Q-L, et al.: Frailty and changes in cognitive function after kidney transplantation. J Am Soc Nephrol 30: 336–345, 2019 10.1681/ASN.2018070726 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 69.

    Haugen CE, Chu NM, Ying H, Warsame F, Holscher CM, Desai NM, et al.: Frailty and access to kidney transplantation. Clin J Am Soc Nephrol 14: 576–582, 2019 10.2215/CJN.12921118 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 70.

    Bui K, Kilambi V, Rodrigue JR, Mehrotra S: Patient functional status at transplant and its impact on posttransplant survival of adult deceased-donor kidney recipients. Transplantation 103: 1051–1063, 2019 10.1097/TP.0000000000002397 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 71.

    McAdams-DeMarco MA, Ying H, Van Pilsum Rasmussen S, Schrack J, Haugen CE, Chu NM, et al.: Prehabilitation prior to kidney transplantation: Results from a pilot study. Clin Transplant 33: e13450, 2019 10.1111/ctr.13450 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 72.

    Chen X, Liu Y, Thompson V, Chu NM, King EA, Walston JD, et al.: Transplant centers that assess frailty as part of clinical practice have better outcomes. BMC Geriatr 22: 82, 2022 10.1186/s12877-022-02777-2 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 73.

    Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, et al.: Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant 19: 984–994, 2019 10.1111/ajt.15198 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 74.

    Oniscu GC, Abramowicz D, Bolignano D, Gandolfini I, Hellemans R, Maggiore U, et al.: Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA. Nephrol Dial Transplant 37: i1–i15, 2021 10.1093/ndt/gfab310 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 75.

    Kim SM, Choi JH, Son MJ, Rim H, Shin HS: Is body mass index a significant independent risk factor for graft failure and patient death in the modern immunosuppressive era? Transplant Proc 52: 3058–3068, 2020 10.1016/j.transproceed.2020.02.158 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 76.

    Puttarajappa CM, Smith KJ, Ahmed BH, Bernardi K, Lavenburg L-M, Hoffman W, et al.: Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity [published online ahead of print Jul 20, 2024]. Am J Transplant, doi:10.1016/j.ajt.2024.07.024 2024 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 77.

    Gill JS, Lan J, Dong J, Rose C, Hendren E, Johnston O, et al.: The survival benefit of kidney transplantation in obese patients. Am J Transplant 13: 2083–2090, 2013 10.1111/ajt.12331 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 78.

    Kukla A, Diwan T, Smith BH, Collazo-Clavell ML, Lorenz EC, Clark M, et al.: Guiding kidney transplantation candidates for effective weight loss: A clinical cohort study. Kidney360 3: 1411–1416, 2022 10.34067/kid.0001682022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 79.

    Clemens KK, Ernst J, Khan T, Reichert S, Khan Q, LaPier H, OK TRANSPLANT Investigators, et al.: Glucagon-like peptide 1 receptor agonists in end-staged kidney disease and kidney transplantation: A narrative review. Nutr Metab Cardiovasc Dis 33: 1111–1120, 2023 10.1016/j.numecd.2023.03.023 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 80.

    Wallace R, Hamblin PS, Tully E, Tran J, Nelson C, Levidiotis V: Case report of the successful use of semaglutide to achieve target BMI prior to renal transplant in two patients with end-stage-kidney-disease. Nephrology (Carlton) 29: 371–374, 2024 10.1111/nep.14277 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 81.

    Touzot M, Ureña-Torres P, Dupuy O: Semaglutide for treatment of obesity in hemodialysis patients waiting for a kidney transplant: New hope? Clin Kidney J 15: 1782–1784, 2022 10.1093/ckj/sfac090 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 82.

    Kassam A-F, Mirza A, Kim Y, Hanseman D, Woodle ES, Quillin RC, et al.: Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy. Am J Transplant 20: 422–429, 2020 10.1111/ajt.15650 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 83.

    Zaminpeyma R, Claus M, Paraskevas S, Court O, Tchervenkov J, Andalib A: Outcomes of kidney transplant recipients who underwent pre-transplant bariatric surgery for severe obesity: A long-term follow-up study. Surg Endosc 37: 494–502, 2023 10.1007/s00464-022-09552-9 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 84.

    Sheetz KH, Woodside KJ, Shahinian VB, Dimick JB, Montgomery JR, Waits SA: Trends in bariatric surgery procedures among patients with ESKD in the United States. Clin J Am Soc Nephrol 14: 1193–1199, 2019 10.2215/CJN.01480219 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 85.

    Fernando S, Varma J, Dengu F, Menon V, Malik S, O’Callaghan J: Bariatric surgery improves access to renal transplantation and is safe in renal failure as well as after transplantation: A systematic review and meta-analysis. Transplant Rev (Orlando) 37: 100777, 2023 10.1016/j.trre.2023.100777 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 86.

    Tourret J, Guiguet M, Lassalle M, Grabar S, Lièvre L, Isnard-Bagnis C, et al.: Access to the waiting list and to kidney transplantation for people living with HIV: A national registry study. Am J Transplant 19: 3345–3355, 2019 10.1111/ajt.15500 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 87.

    Shelton BA, Sen B, Becker DJ, MacLennan PA, Budhwani H, Locke JE: Quantifying the association of individual-level characteristics with disparities in kidney transplant waitlist addition among people with HIV. AIDS 38: 731–737, 2024 10.1097/QAD.0000000000003817 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 88.

    Durand CM, Massie A, Florman S, Liang T, Rana MM, Friedman-Moraco R, HOPE in Action Investigators, et al.: Safety of kidney transplantation from donors with HIV. N Engl J Med 391: 1390–1401, 2024 10.1056/NEJMoa2403733 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 89.

    Durand CM, Zhang W, Brown DM, Yu S, Desai N, Redd AD, HOPE in Action Investigators, et al.: A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. Am J Transplant 21: 1754–1764, 2021 10.1111/ajt.16205 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 90.

    Motter JD, Hussain S, Brown DM, Florman S, Rana MM, Friedman-Moraco R, HOPE in Action Investigators, et al.: Wait time advantage for transplant candidates with HIV who accept kidneys from donors with HIV under the HOPE Act. Transplantation 108: 759–767, 2024 10.1097/TP.0000000000004857 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 91.

    Martin P, Awan AA, Berenguer MC, Bruchfeld A, Fabrizi F, Goldberg DS, et al.: Executive summary of the KDIGO 2022 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 102: 1228–1237, 2022 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 92.

    Chang S-H, Merzkani M, Lentine KL, Wang M, Axelrod DA, Anwar S, et al.: Trends in discard of kidneys from hepatitis C viremic donors in the United States. Clin J Am Soc Nephrol 16: 251–261, 2021 10.2215/CJN.10960720 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 93.

    Molnar MZ, Azhar A, Tsujita M, Talwar M, Balaraman V, Bhalla A, et al.: Transplantation of kidneys from hepatitis C virus-infected donors to hepatitis C virus-negative recipients: One-year kidney allograft outcomes. Am J Kidney Dis 77: 739–747.e1, 2021 10.1053/j.ajkd.2020.10.017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 94.

    Durand CM, Bowring MG, Brown DM, Chattergoon MA, Massaccesi G, Bair N, et al.: Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: An open-label nonrandomized trial. Ann Intern Med 168: 533–540, 2018 10.7326/m17-2871 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 95.

    Sise ME, Strohbehn IA, Chute DF, Gustafson J, Van Deerlin VM, Smith JR, et al.: Preemptive treatment with elbasvir and grazoprevir for hepatitis C-viremic donor to uninfected recipient kidney transplantation. Kidney Int Rep 5: 459–467, 2020 10.1016/j.ekir.2020.01.001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 96.

    Torabi J, Rocca JP, Ajaimy M, Melvin J, Campbell A, Akalin E, et al.: Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients. Transpl Infect Dis 23: e13449, 2021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 97.

    Jay JS, Patterson JA, Zhang Y, Ijioma SC, Carroll NV, Holdford DA, et al.: Cost minimization analysis of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants. J Am Pharm Assoc (2003) 63: 1700–1705.e4, 2023 10.1016/j.japh.2023.06.027 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 98.

    Gordon CE, Adam GP, Jadoul M, Martin P, Balk EM: Kidney transplantation from hepatitis C virus-infected donors to uninfected recipients: A systematic review for the KDIGO 2022 hepatitis C clinical practice guideline update. Am J Kidney Dis 82: 410–418, 2023 10.1053/j.ajkd.2022.12.019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 99.

    Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM: Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 290: 2817–2823, 2003 10.1001/jama.290.21.2817 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 100.

    Gruessner RW, Sutherland DE, Gruessner AC: Mortality assessment for pancreas transplants. Am J Transplant 4: 2018–2026, 2004 10.1111/j.1600-6143.2004.00667.x PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 101.

    Fridell JA, Niederhaus S, Curry M, Urban R, Fox A, Odorico J: The survival advantage of pancreas after kidney transplant. Am J Transplant 19: 823–830, 2019 10.1111/ajt.15106 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 102.

    Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD: Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant 8: 175–182, 2008 10.1111/j.1600-6143.2007.02018.x PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 103.

    Pham PH, Stalter LN, Martinez EJ, Wang JF, Welch BM, Leverson G, et al.: Single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes. Am J Transplant 21: 2810–2823, 2020 10.1111/ajt.16462 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 104.

    Rössler F, Hübel K, Di Natale S, Oberkofler C, Gerber P, Bueter M, et al.: Sleeve gastrectomy enables simultaneous pancreas and kidney transplantation in severely obese recipients. Clin Transplant 35: e14197, 2021 10.1111/ctr.14197 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 105.

    Lonze BE, Baptiste G, Ali NM, Dagher NN, Gelb BE, Mattoo A, et al.: Pancreas transplantation from hepatitis C viremic donors to uninfected recipients. Am J Transplant 21: 1931–1936, 2021 10.1111/ajt.16465 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 106.

    Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, et al.: Simultaneous liver-kidney allocation policy: A proposal to optimize appropriate utilization of scarce resources. Am J Transplant 16: 758–766, 2016 10.1111/ajt.13631 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 107.

    OPTN/UNOS Kidney Transplantation Committee: Simultaneous liver kidney (SLK) allocation policy. Available at: https://optn.transplant.hrsa.gov/media/1192/0815-12_slk_allocation.pdf. Accessed November 25, 2024.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 108.

    Wilk AR, Booker SE, Stewart DE, Wiseman A, Gauntt K, Mulligan D, et al.: Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A two-year review of the OPTN’s allocation policy. Am J Transplant 21: 3593–3607, 2021 10.1111/ajt.16761 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 109.

    Altshuler PJ, Shah AP, Frank AM, Glorioso J, Dang H, Shaheen O, et al.: Simultaneous liver kidney allocation policy and the Safety Net: An early examination of utilization and outcomes in the United States. Transpl Int 34: 1052–1064, 2021 10.1111/tri.13891 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 110.

    Homkrailas P, Ayoub WS, Martin P, Bunnapradist S: Kidney utilization and outcomes of liver transplant recipients who were listed for kidney after liver transplant after the implementation of safety net policy. Clin Transplant 36: e14522, 2022 10.1111/ctr.14522 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 111.

    Schold JD, Mohan S, Jackson WE, Stites E, Burton JR, Bababekov YJ, et al.: Differential in kidney graft years on the basis of solitary kidney, simultaneous liver-kidney, and kidney-after-liver transplants. Clin J Am Soc Nephrol 19: 364–373, 2024 10.2215/CJN.0000000000000353 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 112.

    Itagaki S, Toyoda N, Moss N, Mancini D, Egorova N, Mikami T, et al.: Outcomes of simultaneous heart and kidney transplantation. J Am Coll Cardiol 81: 729–740, 2023 10.1016/j.jacc.2022.11.053 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 113.

    Gallo M, Trivedi JR, Schumer EM, Slaughter MS: Combined heart-kidney transplant versus sequential kidney transplant in heart transplant recipients. J Card Fail 26: 574–579, 2020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 114.

    OPTN: Establish elegibility criteria and safety net for heart-kidney and lung-kidney allocation. Available at: https://optn.transplant.hrsa.gov/media/erucde2m/policy-notice_est-elgblty-crit-and-safety-for-hrt-kid-and-lung-kid-alloc_mot.pdf. Accessed October 27, 2024

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 115.

    Kumar A, Bonnell LN, Thomas CP: Severely reduced kidney function assessed by a single eGFR determination at the time of an isolated heart transplant does not predict inevitable posttransplant ESKD. Transplantation 107: 981–987, 2023 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 116.

    Okumura K, Ohira S, Kai M, Misawa R, Wolfe K, Sogawa H, et al.: High rate of kidney graft failure after simultaneous heart-kidney transplantation. Kidney360 5: 252–261, 2024 10.34067/kid.0000000000000365 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 117.

    Westphal SG, Langewisch ED, Robinson AM, Wilk AR, Dong JJ, Plumb TJ, et al.: The impact of multi-organ transplant allocation priority on waitlisted kidney transplant candidates. Am J Transplant 21: 2161–2174, 2021 10.1111/ajt.16390 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 118.

    Nanayakkara DD, Schaenman J: Screening of donors and recipients for infections prior to solid organ transplantation. Curr Opin Organ Transplant 24: 456–464, 2019 10.1097/mot.0000000000000671 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 119.

    Malinis M, Boucher HW, AST Infectious Diseases Community of Practice: Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33: e13548, 2019 10.1111/ctr.13548 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 120.

    Attieh RM, Wadei HM, Mao MA, Mao SA, Pungpapong S, Taner CB, et al.: The impact of induction therapy on the risk of post-transplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch. Am J Transplant 24: 1486–1494, 2024 10.1016/j.ajt.2024.02.028 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 121.

    Ryan RJ, Bentall AJ, Issa N, Dean PG, Smith BH, Stegall MD, et al.: Outcomes of older primary kidney transplant recipients by induction agent and high-risk viral discordance status in the United States. Transplant Direct 10: e1698, 2024 10.1097/txd.0000000000001698 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 167 167 119
Full Text Views 120 120 105
PDF Downloads 202 202 179